ArticleContemporary clinical trials communications2022

Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.

Jason E Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.